Probiotics: Recent understandings and biomedical applications

Current Trends in Biotechnology and Pharmacy

Volumn 6, Issue 1, 2012, Pages 1-14

  Adam, Jamila K ^a   Odhav, Bharti ^a   Naidu, K Suresh Babu ^a  

^a DURBAN UNIVERSITY OF TECHNOLOGY   (South Africa)

Author keywords

Bacillus; Bifidobacterium; Biomedical Applications; Lactobacillus; Probiotics

Indexed keywords

PROBIOTIC AGENT;

BACILLUS; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIFIDOBACTERIUM; CONSTIPATION; DECISION MAKING; DIARRHEA; DIET SUPPLEMENTATION; DRUG FORMULATION; DRUG SAFETY; ENTEROCOCCUS; GENETIC ANALYSIS; HUMAN; INTESTINE INFECTION; LACTOBACILLUS; MEDICAL RESEARCH; NONHUMAN; PEDIOCOCCUS; PRACTICE GUIDELINE; REVIEW; STRAIN IDENTIFICATION; STREPTOCOCCUS;

BIFIDOBACTERIUM; LACTOBACILLUS;

EID: 84856195811     PISSN: 09738916     EISSN: 22307303     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Anukam, K.C., Osazuwa, E.O., and Greigor R. (2005). Knowledge of probiotics by Nigerian clinicians. Int. J. Nat Appl. Sci, 1: 65-69.
2. Barbosa, T. M., Serra, C. R., La Ragione, R. M., Woodward, M.J. and Henriques, A.O. (2005). Screening for Bacillus isolates in the broiler gastrointestinal tract. Appl. Environ. Microbiol, 71: 968-978.
3. Bolotin, A., Wincker, P., Mauger, S., Jaillon, O., Malarme, K., Weissenbach, J., Ehrlich, S.D. and Sorokin A. (2001). The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL 1403. Genome Res, 11: 731-753.
4. Berg, R.D. and Garlington, A.W. (1979). Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in the gnotobiotic mouse model. Infect. Immunol, 23:401-411
5. Bernet, M.F., Brassart, D., Neeser, J.R. and Servin A.L. (1994). Lactobacillus acidophilus LA-1 binds to cultured human intestinal cell-lines andinhibits cell attachment and cell invasion by enterovirulent bacteria. Gut, 35:483-9.
6. Bengmark, S. (2000). Colonic food: preand probiotics. Am. J. Gastroenterol, 95: S5-S7.
7. Castex, F., Corthier, G., Jovert, S., Elmer, G.W., Lucas, F. and Bastide, M. (1990). Preventionof Clostridium difficile-induced experimental pseudomembranouscolitis by Saccharomyces boulardii: a scanning electron microscopicand microbiological study. J. Gen. Microbiol, 136:1085-1089.
8. Cannon, M.L. (2011). A review of probiotic therapy in preventive dental practice. Probiotics and Antimicrobial Prot, 3:63-67.
9. Cutting, S.M. (2011). Bacillus probiotics. Food Microbiol, 28: 214-220
10. Christophe Lay. (2009). Molecular tools for investigating the gut microbiota. In. Charalampopoulos D and Rastall RA, editors. Prebiotics and Probiotics Science and Technology. New York: Springer, pp 33-78.
11. Champagne, C. P. (2009). Recent advances in probiotics and prebiotics in foods: product applications, and wellbeing. Aryana K, editor. DEStech Publications, Lancaster, PA (in press)
12. Champagne, C.P., Gardner, N.J. and Roy, D. (2005). Challenges in the addition of probiotic cultures to foods. Crit. Rev. Food Sci. Nutr, 45: 61-84
13. Chafen, J.J.S., Newberry, S.J., Reidl, M.A., Bravata, D.M., Maglione, M., Suttorp M.J., Sundaram, V., Paige, N.M., Towfigh, A., Hulley, B.J. and Shekelle, P.G. (2010). Diagnosing and managing common food allergies. JAMA, 303: 1848-1856.
14. Commane, D., Hughes, R., Shrott, C. and Rowland, I. (2005). The potential mechanisms involved in the anticarcinogenic action of probiotics. Mutation Research, 591: 276-289.
15. Cruz, A.G., Antunes, A.E.C., Sousa, O.P., Faria, J.A.F. and Saad, S.M.I. (2009). Icecream as a probiotic food carrier. Food Res Int, 42: 1233-1239
16. Day, A.S. (2002). Use of complementary and alternative therapies and probiotic agents by children attending gastroenterology outpatient clinics, J Ped Child Health, 38: 343-346.
17. Duffy, L.D. (2000). Interactions mediating bacterial translocation in the immature intestine. J Nutrition, 130:432-436.
18. Ezendam, J. and Loveren, H. (2006). Probiotics: Immunomodulation and evaluation of safety and efficacy. Nutr Rev, 64: 1-14.
19. FAO/WHO working group (2001). Report of Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. World Health Organisation and Food and Agriculture Organisation of the United Nations, London, Ontario, Canada.
20. FAO/WHO. Probiotic in foods. Health and nutritional properties and guidelines for evaluation. In FAO Food and Nutrition; 2006 p 85 ISBN 92-5-105513-0. Also available at ftp://ftp.fao.org/docrep/fao/ 009/a0512e/a0512e00.pdf.
21. Farkas, D.F. (1977). Unit operations concepts optimize operations. Chemtech, 7:428-432
22. Fric, P. (2007). Probiotics and Prebioticsrenaissance of a therapeutic principle. CEJ Med, 2: 237-270
23. Galdeano, M.C., LeBlanc, M.A., Vinderola, G., Bibasbonet, M.E. and Perdigon, G. (2007). Proposed model: Mechanisms of immunomodulation induced by probiotic bacteria. Clin Vac Immun, 14:485-492
24. Gupta, V. and Garg, R. (2009). Probiotics. Indian J Med Microbiol, 27:202-209
25. Gasser, F. (1994). Safety of lactic acid bacteria and their occurrence in human clinical infections. Bull Instr Pasteur, 92:45-67.
26. Grozdanov, L., Raasch, C., Schulze, J., Sonnenborn, U., Gottschalk, G., Hacker, J. and Dobrindt, U. (2004). Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J Bacteriol, 186: 5432-5441
27. Goldin, B.R. and Gorbach, S.L. (1992). Probiotics for humans. In: Fuller R, ed. Probiotics, the scientific basis. London: Chapman and Hall, pp. 355-76.
28. Girgis, H.S., Smith, J., Luchansky, J.B. and Klaenhammer, T. R (2002). Stress adaptations of lactic acid bacteria. In Yousef AE, Juneja VK Editors. Microbial stress adaptation and food safety; New York: pp. 160-211.
29. Gibson, G. R and Roberfroid, M.B. (1995). Dietary modulation of the human colonicmicrobiota: Introducing the concept of prebiotics. J of Nutrition 125:1401-1412.
30. Gould, G.W. (1995). New Methods of Food Preservation. New York: Chapman and Hall
31. Heldman, D.R. and Lund, D.B. (1995). Handbook of Food Engineering, Marcel Dekker, New York.
32. Hibberd, P.L. and Davidson, L. (2008). Probiotics foods and drugs: Impact of US regulatory status on design of clinical trials. CID, 46: 137-140.
33. Hooper, W.L., Wong, M.H., Thelin, A., Hansson, L., Falk, P.G. and Gordon, J.I. (2001). Molecular analysis of commensal host-microbial relationships in the intestine. Science, 291: 881-884.
34. Husni, R.N., Gordon, S.M., Washington, J.A. and Longworth, D.L. (1997). Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis, 25: 1048-1055.
35. Kleerebezem, M., Boekhorst, J., Van Kranenburg, R., Molennar, D. O.P., Kuipers, O.P., Leer, R., Tarchini, R., Peter, S.A., Sandbrick, H.M., Fiers, M.W.E.J., Stiekema, W., Lankhorst, R.M.K., Bron P.A., Hoffer, S.M., Groot, M.N.N., Kerkhoven, R., Vries, M. D., Ursing, B., De Vos, M. D and Siezen, R. J (2003). Complete genome sequence of Lactobacillu splantarum WCFS1. Proc Natl Acad Sci, 100: 1990-1995.
36. Martha, I., Olmos, A. and Oberhelman, R.A. (2001). Probiotic agents and infectious diseases: A modern perspective on a traditional therapy. CID, 32: 1567-1576.
37. Marteau, P., Flourie, B., Pochart, P. and Bourlioux, J.C.R. (1990). Effect of chronic ingestion ofa fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic florain humans. Am. J. Clin. Nutr, 52:685-688
38. Marteau, P.R., Vrese, M., Cellier, C.J. and Schrezenmeir, J. (2001). Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr, 73: 430-436.
39. Ooi, L.G. and Liong, M.T. (2010). Cholesterol-Lowering Effects of Probiotics and Prebiotics: A Review of in Vivo and in Vitro Findings. Int. J. Mol. Sci, 11: 2499-2522
40. Kaur, I.P., Chopra, K. and Saini, A. (2002). Probiotics: potential pharmaceutical applications. Eur J Pharma Sci, 15: 1-9
41. Knorr, D. (1998). Technology aspects related to microorganisms in functional foods. Trends in Food Sci Technol, 9: 295-306.
42. Lee, Y.K. and Salminen, S. (1995). The coming age of probiotics. Trends Food Sci Technol 6:241-245.
43. nd Eds. Wiley.
44. Lee, S.H., Lillehoj, H.S., Park, D. W, Hong, Y.H. and Lin, J.J. (2007). Effects of Pediococcus and Saccharomyces-based probiotic (MitoMax) on coccidiosis in broiler chickens. Comparative Immunomodulation studies. Microbiol Infect Dis, 30:261-268
45. Liong, M.T. (2008). Safety of probiotics: translocation and infection. Nutrion Review, 66:192-202
46. McFarland, L. (2000). A review of evidences of health claims for biotherapeutic agents. Microbiol Ecol Health Dis, 12:65-76.
47. MacFarlane, G.T. and Cummings, J.H. (2002). Probiotics, infection and immunity. Curr. Opin. Infect. Dis, 15:501-506.
48. Mullard, A. (2008). Microbiology: the inside story. Nature, 453: 578-80
49. Neuno, C. and Narbard, A. (2011). Probiotic assessment of Enterococcus faecalis CP58 isolated during an in vitro screening of lactic acid bacteria. Int J Food Microbiol, 2: 390-394
50. Ng, S.C., Hart, A.C., Kamm, M.A., Stagg, A.L. and Knight, S.C. (2009). Mechanisms of action of probiotics: Recent Advances. Inflamm Bowel Dis, 15: 300-310
51. Nwogu, N.A., Olaji, E.D. and Eghomwanre, A.F. (2011). Application of probiotics in Nigeria aquaculture: current status, challenges and prospects. Int Res Microbiol, 2: 215-219.
52. Parvez, S., Malik, K.A., Ah Kang, S. and Kim, H.Y. (2006). Probiotics and their fermented food products are beneficial for health. Journal of Applied Microbiology, 100: 1171-1185.
53. Iris, D and Daniel, R. (2005). Probiotics in inflammatory bowel disease: possible mechanism of action. Curr Opi Gastroenterol, 21: 426-434.
54. Rinkinen, M., Jalava, K., Westermarck, E., Salminen, S. and Ouwehand, A.C. (2003). Interaction between probiotic lactic acid bacteria and canine enteric pathogens a risk factor for intestinal Enterococcus faecium colonization. Veterinary Microbiol, 92:111-119.
55. Ross, R.P., Desmond, C., Fitzgerald, G.F. and Stanton (2005). Overcoming the technological hurdles in the development of probiotic foods. J Appl Microbiol, 98: 1410-1417
56. Rodriguez, A.V., Baigorí, M.D., Alvarez, S., Castro, G.R. and Oliver, G.(2001). Phosphatidylinositol-specific phospholipase C activity in Lactobacillus rhamnosus with capacity to translocate. FEMS Microbiol Lett, 204:33-38.
57. Sartor, R.B. (2003). Targeting enteric bacteria in treatment of inflammatory bowel diseases: "Why, how and when". Curr Opin Gastroenterol, 19: 358-365
58. Sen, R., Pal, D., Kodali, V.B., Das, S. and Ghosh, S.K. (2010). Molecular characterization and invitro analyses of a sporogenous bacterium with potential probiotic properties. Probiotics Antimicro Pro, 2: 152-161
59. Sloan, A.E. (2004). The top 10 functional food trends. Food Technol, 58: 28-51
60. Saxelin, M., Korpela, R. and Mayara-Makinen, A. (2003). Introduction: Classifying functional dairy products. In Mattila-Sandholm TT, Saarela M, editors. Functional dairy products. pp. 1-16.
61. Saxelin, M., Grenov, B., Svensson, U., Fonden, R., Reniero, R. and Mattila-Sandholm, T. (1999). The technology of probiotics. Trends Food Sci Tech, 10:387-392
62. Sanz, Y. (2007). Ecological and functional implications of the acid-adaptation ability of Bifidobacterium: A way of selecting improved probiotic strains. Int Dairy J, 17: 1284-1289.
63. Schlegel, L., Lemerle, S and Geslin, P. (1998). Lactobacillus species as opportunistic pathogens in immunocompromised patients. Eur J Clin Microbiol Infect Dis,17:887-888
64. Shah, N. P. (2004). Probiotics and prebiotics. Agro-Food Ind Hi-tech, 15:13-16.
65. Simark-Mattsson, C., Jonsson, R., Emilson, C. G and Roos, K. (2009). Final pH affects the interference capacity of naturally occurring oral Lactobacillus strains against mutans streptococci Arch OralBiol, 54:602-607
66. Stanton, C., Gardiner, G., Meehan, H., Collins, K., Fitzgerald, G., Lynch, P.B. and Ross, R. P (2001). Market potential for probiotics. Am.J. Clin. Nutr 73: 476S-483S
67. Schell, M. A., Karmirantzou, M., Snel, B., Vilanova, D., Berger, B. and Pessi, G. (2002). The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc Natl Acad Sci, 99: 14422-14427
68. Senok, A.C., Ismaeel, A.Y. and Botta, G.A. (2005). Probiotics: facts and myths. Clin Microbiol Infec, 11: 958-966.
69. Siuta-Cruce, P. and Goulet, J. (2001). Improving probiotic survival rates. Food Tech, 55: 38-40 42
70. Tannock, G.W. (1997). Probiotic properties of lactic-acid bacteria: plenty of scope for fundamental R & D. Trends Biotechnol, 15:270-74.
71. Talwalkar, A., Miller, C.W., Kailasapathy, K. and Nguyen, M.H. (2004). Effect ofpackaging materials and dissolved oxygen on the survival of probiotic bacteriain yoghurt. International Journal of Food Science and Technology, 39: 605-611
72. Tuohy, K.M., Pinart-Gilberga, M., Jones, M., Hoyles, L., McCartney, A. L and Gibson, G.R. (2007). Survivability of a probiotic Lactobacillus casei in the gastrointestinal tract of healthy human volunteers and its impact on the faecal microflora. J Appl Microbiol, 102: 1026-1032
73. Vasiljevic, T. and Shah, N.P. (2008). Probiotics-from Metchnikoff to bioactives. Int Dairy J, 18: 714-728
74. Vanderhoof, J.A. (2000). Probiotics and intestinal inflammatory disorders in infants and children. In. Wu, Sheng M, Cai, Wei, editors. Bacterial colonization of the gut and use of pre and probiotics: Proceedings of a symposium. J Ped Gastr Nutr, pp.34-38.
75. Zoetendal, E.G., Akkermans, A.D.L. Akkermans-van Vliet W. M., de Visser J. A. G. M. and de Vos, W. M.(2001)The host genotype affects the bacterial community in the human gastrointestinal tract. Microbiol Eco Health Dis13: 129-134.